| 000 | 01066 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515184907.0 | ||
| 264 | 0 | _c20091116 | |
| 008 | 200911s 0 0 eng d | ||
| 022 | _a0035-3787 | ||
| 024 | 7 |
_a10.1016/j.neurol.2009.07.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHammers, A | |
| 245 | 0 | 0 |
_aWhat has positron emission tomography told us about the epileptogenic zone? _h[electronic resource] |
| 260 |
_bRevue neurologique _cOct 2009 |
||
| 300 |
_a739-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnticonvulsants _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain Chemistry _xdrug effects |
| 650 | 0 | 4 |
_aEpilepsy _xdiagnostic imaging |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 |
_aReceptors, Drug _xdrug effects |
| 650 | 0 | 4 |
_aSeizures _xdiagnostic imaging |
| 773 | 0 |
_tRevue neurologique _gvol. 165 _gno. 10 _gp. 739-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neurol.2009.07.012 _zAvailable from publisher's website |
| 999 |
_c19140115 _d19140115 |
||